SOURCES SOUGHT
A -- Rodent Testing to Identify Pharmacotherpaies for Substance Dependence
- Notice Date
- 4/11/2012
- Notice Type
- Sources Sought
- NAICS
- 541712
— Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, 6001 Executive Boulevard, Room 4211 - MSC 9559, Bethesda, Maryland, 20892, United States
- ZIP Code
- 20892
- Solicitation Number
- HHS-NIH-NIDA-SBSS-13-001
- Archive Date
- 5/11/2012
- Point of Contact
- Lisa V. Bielen, Phone: 301.443.6677
- E-Mail Address
-
lisa.bielen@nih.gov
(lisa.bielen@nih.gov)
- Small Business Set-Aside
- N/A
- Description
- This Small Business Sources Sought is also posted on FBO.gov under Number N01DA-13-8908_SourcesSought - link provided here: https://www.fbo.gov/index?mode=form&id=5cdc25e7570ddfce900cf7a29c8c33d9&tab=ntype The purpose of this small business Sources Sought announcment is to determine the availability of qualified small businesses (e.g., 8(a), veteran-owned small businesses, service-disabled veteran owned small businesses, HUB Zone small businesses, small disadvantaged businesses, and women owned small businesses) having the in-house capability and multi-disciplinary knowledge, expertise, and experience required to: provide preclinical evaluation of test compounds as potential pharmacotherapies for substance abuse. To this end, the offeror and technical personnel need to have the capability and experience to conduct experiments evaluating compounds in the mouse locomotor activity, rat drug discrimination, rat conditioned place preference, mouse stress-induced potentiation of conditioned place preference, and rat self-administration paradigms. The offeror and technical staff also need to have experience conducting these types of experiments using cocaine, methamphetamine, nicotine, THC, and hallucinogens. Evidence of experience must be documented through publications using the relevant behavioral models listed above. In addition, the offeror needs to have the dedicated laboratory space, animal care facilities, and equipment required to conduct these behavioral assays. Proprietary compounds will be evaluated using established protocols, and the resulting data will be utilized by the Addiction Treatment Discovery Program of the NIDA Division of Pharmacotherapies and Medical Consequences of Drug Abuse. The successful offeror must submit documentation of a current DEA registration for Schedules II - IV controlled substances and the eligibility to obtain Schedule I prior to award. All offerors must be in compliance with the NIH guidelines on the care and use of laboratory animals. Offerors should demonstrate capability to administer and coordinate interrelated tasks in an effective and timely manner. In addition to demonstrating the above capabilities, information sent should be relevant and specific in the technical area under consideration on each of the following qualifications: 1) Experience: An outline of previous similar projects, specifically the techniques employed in the areas described above; 2) Personnel: Name; professional qualifications; specific experience in the work requested. We will consider appropriateness of professional and technical personnel classifications. We will consider any other specific and relevant information about this particular announcement that would improve our evaluation of respondents. Organizations should demonstrate capability to administer and coordinate interrelated tasks in an effective and timely manner. Documentation may include, but is not limited to, contracts in which the organization performed (Government and commercial); references, i.e., names, titles, telephone numbers and any other information serving to document the organizations capability; and awards or commendations. THIS IS NOT A REQUEST FOR PROPOSALS: This notice is for information and planning purposes only and does not commit the Government to any contractual agreement. The Government does not intend to award a contract based on responses under this announcement nor otherwise pay for the preparation of any information sent for the Government's use. Any proprietary information should be so marked. All capability statements should provide the following: 1) company name and address; 2) point of contact, 3) phone/fax/email; 4) NAICS Code(s), 5) business size and status; 6) capability information in response to the requirement and qualifications identified in this notice; and 7) type(s) of business, if any (e.g.,: small, Veteran-owned, service-disabled Veteran-Owned, women-owned, 8(a), Small Disadvantaged Business (SDB), and Historically Underutilized Business Zone (HUBZone).
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NIDA-01/HHS-NIH-NIDA-SBSS-13-001/listing.html)
- Record
- SN02719505-W 20120413/120411235300-0d7e9812caed870708c7ca0a327af72a (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |